Balanced news tone
News Sentiment
ABT sentiment intelligence
Abbott Laboratories news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
75/100 classification confidence.
directly relevant articles
high-authority source matches
+7.6% over one week, +14.6% over four weeks, trend inactive, and near fair-value range.
Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Jul 2026 13:10
- Source
- Ad-hoc-news.de
Lobbying Update: $1,150,000 of ABBOTT LABORATORIES lobbying was just disclosed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2026 03:07
- Source
- Quiver Quantitative
Abbott Laboratories stock trades steadily as diagnostics and medical devices underpin earnings momen
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Jul 2026 02:00
- Source
- Ad-hoc-news.de
Abbott Laboratories (ABT) Stock Faces Margin Squeeze As Net Profit Slide Tests Growth Narrative
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 18 Jul 2026 07:00
- Source
- Sahm
Abbott Stock: Bear Trap Over, With Richer Return Prospects (NYSE:ABT)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jul 2026 03:23
- Source
- Seeking Alpha
Abbott Just Showed Its Growth Engine Has More Than One Cylinder
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Jul 2026 22:55
- Source
- Trefis
Abbott Laboratories Stock Surges 11% as Company Lifts Full Year Profit Guidance
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 17 Jul 2026 15:51
- Source
- TIKR.com
Can Abbott Stock Deliver on Its Second-Half Growth Promise?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Jul 2026 12:16
- Source
- Trefis
Abbott Laboratories: Pick Up This Dividend King Deal Now
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 17 Jul 2026 11:30
- Source
- Seeking Alpha
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 17:45
- Source
- MarketBeat
Stocks making the biggest moves midday: Manpower, Abbott, UnitedHealth, TSMC & more
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 16:03
- Source
- CNBC
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 15:50
- Source
- Market source
Abbott raises 2026 earnings outlook after second-quarter results beat expectations (ABT)
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 16 Jul 2026 12:43
- Source
- Market source
What Investors Don’t Understand About Abbott Laboratories
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 11:40
- Source
- 24/7 Wall St.
Abbott: Q2 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 11:40
- Source
- KVUE
Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 13 Jul 2026 07:00
- Source
- Market source
Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector’s 9% Earnings Drop
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Jul 2026 20:33
- Source
- TechStock²
Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 Jul 2026 07:00
- Source
- Market source
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Abbott Laboratories Q2 Earnings Preview: A Contrarian Buy Opportunity Worth Considering
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 03 Jul 2026 07:00
- Source
- Seeking Alpha
Abbott Laboratories (ABT) Stock After Recent Rebound Is There Still Value Left
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 07:00
- Source
- Market source
Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- 24/7 Wall St.
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Jun 2026 03:24
- Source
- AOL.com
Abbott Laboratories Stock Is Getting Decimated, But the Smart Money Senses Opportunity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Barchart.com
Abbott Laboratories, Coca-Cola, and Walmart: Top Recession-Proof Stocks for 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- IndexBox
Abbott Laboratories Is On Sale, Don't Overlook It
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 May 2026 07:00
- Source
- Seeking Alpha
Abbott Stock Is Trading at 52-Week Lows but Insiders Are Gobbling Up Shares of This Blue-Chip Dividend Payer
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 05 May 2026 07:00
- Source
- Barchart.com
Abbott trims 2026 profit forecast on Exact deal hit, shares fall
- Tone
- Negative 38/100
- Event
- Earnings
- Published
- 16 Apr 2026 07:00
- Source
- The Globe and Mail
UBS reiterates Abbott Labs stock rating on structural heart upside
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 13 Mar 2026 07:00
- Source
- Investing.com
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source